Autoimmune Diseases
Q4IF1.7SJR0.611
GB
GBJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.611 | Q2 | 68.3% | |
| 2024 | — | — | 0.316 | Q3 | 47.4% | |
| 2023 | 1.7 | Q4 | 17.3% | 0.556 | Q2 | 68.4% |
| 2022 | 4.0 | 43.8% | 0.565 | Q2 | 70.1% | |
| 2021 | — | 14.6% | 0.563 | Q2 | 70.9% | |
| 2020 | — | — | 0.681 | Q2 | 75.4% | |
| 2019 | — | — | 0.607 | Q3 | 72.9% | |
| 2018 | — | — | 0.446 | Q3 | 62.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2090-0422
ISSN
2090-0430
country
GBcoverage
2010-2024